Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CO

Global Cord Blood (CO)

Global Cord Blood Corporation

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:CO

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
25/04/2024	22h02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
17/04/2024	15h03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
19/03/2024	21h07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
11/03/2024	21h01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
05/09/2023	18h18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:CO	Global Cord Blood Corporation
22/06/2023	15h11	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NYSE:CO	Global Cord Blood Corporation
02/06/2023	20h39	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
13/04/2023	21h14	PR Newswire (US)	GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALS	NYSE:CO	Global Cord Blood Corporation
13/04/2023	21h08	PR Newswire (US)	GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALS	NYSE:CO	Global Cord Blood Corporation
10/04/2023	22h17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
03/03/2023	22h20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
03/02/2023	20h39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:CO	Global Cord Blood Corporation
03/02/2023	14h01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NYSE:CO	Global Cord Blood Corporation
02/12/2022	22h07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
31/10/2022	21h03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
21/10/2022	23h15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
26/09/2022	22h07	Business Wire	Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands	NYSE:CO	Global Cord Blood Corporation
23/09/2022	20h07	TipRanks	Global Cord Blood trading halted by NYSE for ‘regulatory concern’	NYSE:CO	Global Cord Blood Corporation
23/09/2022	19h52	Business Wire	The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation	NYSE:CO	Global Cord Blood Corporation
24/08/2022	15h02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NYSE:CO	Global Cord Blood Corporation
16/08/2022	22h26	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NYSE:CO	Global Cord Blood Corporation
16/08/2022	22h16	PR Newswire (US)	Global Cord Blood Corporation Files Annual Report on Form 20-F	NYSE:CO	Global Cord Blood Corporation
02/08/2022	14h01	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NYSE:CO	Global Cord Blood Corporation
06/07/2022	22h22	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
06/07/2022	22h16	PR Newswire (US)	Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM	NYSE:CO	Global Cord Blood Corporation
05/07/2022	22h16	PR Newswire (US)	Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022	NYSE:CO	Global Cord Blood Corporation
27/06/2022	14h02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:CO	Global Cord Blood Corporation
22/06/2022	22h01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NYSE:CO	Global Cord Blood Corporation
17/06/2022	18h49	Dow Jones News	Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND	NYSE:CO	Global Cord Blood Corporation
16/06/2022	22h20	PR Newswire (US)	Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis	NYSE:CO	Global Cord Blood Corporation

Showing the most relevant articles for your search:NYSE:CO

1 2 3 4 5 6 7 8 9 10 Next >>

Capital One Financial

Infineon Technologies

Coperatieve Rabobank UA

NLBNPIT1U5V2 20241220 150

State Street Global Advi...

Tempo Automation

B Riley Principal Merger

Cooperatieve Rabobank UA...

NLBNPIT1V6I6 20991231 0....

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen